This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The Medical College of Wisconsin, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Chris A Reid: Innovator in Gene Therapy
Introduction
Chris A Reid is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. With a total of 3 patents, Reid's work is paving the way for innovative medical solutions.
Latest Patents
Reid's latest patents include a groundbreaking invention titled "Riboswitch modulated gene therapy for retinal diseases." This invention provides constructs comprising modified riboswitches to regulate the expression of a transgene within a subject. The methods outlined in this patent aim to treat diseases, specifically eye diseases, showcasing Reid's commitment to advancing medical science.
Career Highlights
Chris A Reid is affiliated with the Medical College of Wisconsin, Inc., where he continues to push the boundaries of research and innovation. His work is characterized by a focus on developing novel therapeutic approaches that can significantly impact patient care.
Collaborations
Reid collaborates with esteemed colleagues, including Daniel M Lipinski, to enhance the scope and effectiveness of his research. Their combined expertise contributes to the advancement of gene therapy techniques.
Conclusion
Chris A Reid's contributions to gene therapy exemplify the spirit of innovation in the medical field. His patents and collaborative efforts are vital in the ongoing quest to improve treatments for retinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile